Johannes Gutenberg-Universität Mainz
- 6131/39-0
Mueller, Kai W.; Dreier, Michael; Woelfling, Klaus
Personality traits and their role as risk modifiers in gaming disorder and internet use disordersCURRENT OPINION IN PSYCHIATRY. Bd. 36. H. 1. 2023 S. 75-79
Schmidt, Marcus; Denkert, Carsten; Rhiem, Kerstin et al.
Personalized medicine-from translational research to clinical practiceGYNAKOLOGIE. Bd. 56. H. 5. 2023 S. 341-346
Schoretsanitis, Georgios; Meyer, Jonathan M.; Conca, Andreas et al.
Personalized switching from oral to long-acting injectable second-generation antipsychotics in schizophrenia treatment using pharmacokinetic considerationsEXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. Bd. 19. H. 4. 2023 S. 189-202
Stöbel-Richter, Y; Brähler, E
Persönliche Kinderwunschmotive und Einstellungen zum Kinderwunsch in Ost- und Westdeutschland. Ergebnisse einer Repräsentativbefragung.Kasinger, C., Heller, A., & Brähler, E. (Hrsg). Das Nachbeben der deutschen Vereinigung. Gießen: Psychosozial-Verlag 2023
Depenbusch, Johanna; Sweegers, Maike G.; Aaronson, Neil K. et al.
PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countriesSUPPORTIVE CARE IN CANCER. Bd. 31. H. 5. 2023
Brose, Alexander; Michalski, Kerstin; Ruf, Juri et al.
PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohortCANCER IMAGING. Bd. 23. H. 1. 2023
Boeckmans, Joost; Gatzios, Alexandra; Schattenberg, Joern M. et al.
Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunitiesARCHIVES OF TOXICOLOGY. 2023
Mustafa, Al-Hassan M.; Kramer, Oliver H.
Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat CancerPHARMACOLOGICAL REVIEWS. Bd. 75. H. 1. 2023 S. 35-61
Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphomaBLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150
Abou-Alfa, Ghassan K.; Galle, Peter R.; Chao, Yee et al.
PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular CarcinomaLIVER CANCER. 2023